The aim of the present study was to examine whether MS patients do have a repertoire of CD4+ T cells that recognize endogenous idiotopes predicted as stimulatory in silico, and that are highly transcribed the patient's own CSF. This evidence concerns the gene CD4 and myeloid sarcoma.